Heska

$262.02 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Heska

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.

Stock Analysis

last close $258.38
1-mo return 12.2%
3-mo return 35.2%
avg daily vol. 36.98T
52-week high 263.62
52-week low 93.26
market cap. $2.5B
forward pe 4102
annual div. -
roe -0.4%
ltg forecast -
dividend yield -
annual rev. $246M
inst own. 98.3%
baraka

Subscribe now for daily local and international financial news

Subscribe